Golubnitschaja O, Baban B, Boniolo G, Wang W, Bubnov R, Kapalla M, et al
Inform Health Soc Care
In Figure8 we show the effect of two-fold and four-fold increases in P450 activity on NAPQI covalent binding at different doses of APAP
Richeldi L, Fernndez Prez ER, Costabel U, Albera C, Lederer DJ, Flaherty KR, Ettinger N, Perez R, Scholand MB, Goldin J, Peony, Yu KH, Neff T, Porter S, Zhong M, Gorina E, Kouchakji E, Raghu G (2020) Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial